Subpoena Duces Tecum and Securities Exchange Commission

Amedisys: The investigation concerns whether Amedisys and certain of its officers and/or directors have violated Sections 10 and 20 of the Securities Exchange Act of 1934, according to Market Watch. On May 28, 2015, the Company announced in an Securities and Exchange Commission filing that, "on May 21, 2015, it received a Subpoena Duces Tecum issued by the U.S. Department of Justice. AMED, -2.54% Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 237. The Subpoena requests the delivery of information regarding 53 identified hospice patients to the United States Attorney Office for the District of Massachusetts. The Subpoena generally covers the period from January 1, 2011, through the present." On this news, shares of Amedisys fell $1.14 per share, to 30.69, or more than 3.58%, on May 29, 2015. It also requests the delivery of documents relating to the Company hospice clinical and business operations and related compliance activities. (news.financializer.com). As reported in the news.